Jami Rubin

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Jami Rubin is focused on the Healthcare sector with 196 price targets and ratings documented since 2012 spanning on 12 stocks. Previously, Jami Rubin worked at GOLDMAN SACHS. Analyst's average stock valuation to be materialised ratio is 81.11% with an average time for price targets to be met of 494.67 days.

Most recent stock forecast was given on TEVA, Teva Pharmaceutical Industries Limited at 01-Oct-2018.

Jami Rubin best performing recommendations are on PRGO (PERRIGO COMPANY PLC).
The best stock recommendation documented was for PRGO (PERRIGO COMPANY PLC) at 1/30/2017. The price target of $75 was fulfilled within 16 days with a profit of $8.03 (11.99%) receiving and performance score of 7.49.

Average potential price target upside

of $35.07 (60.58%) on ABBV (ABBVIE INC).
of $30.25 (16.57%) on AGN.
of $19.22 (53.62%) on BMY (BRISTOL-MYERS SQUIBB COMPANY).

Currently, out of the existing stock ratings of Jami Rubin - 7544 which are a Buy (56.16%), 3484 which are a Hold (25.94%), 2404 which are a Sell (17.9%)